SGLT2 inhibitors in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis

7 April 2022 (18:09 - 18:18)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Vasiliki Tsampasian

University of East Anglia, Norwich (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail

Ventricular-arterial coupling derived from proximal aortic stiffness: impact on aerobic capacity across the heart failure spectrum.

Doctor N. Pugliese (Pisa, IT)

Abstract Slides Video

Presentation thumbnail

High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort

Doctor P. Wang (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

Insomnia was associated with increased risk of recurrent cardiovascular events in coronary heart disease patients

Mr L. Frojd (Drammen, NO)

Abstract Slides Video

Presentation thumbnail

Effects of once-weekly semaglutide on coronary outcomes in patients with type 2 diabetes mellitus with or at high risk for cardiovascular disease: insights from the SUSTAIN-6 trial

Doctor A. Kolkailah (Dallas, US)

Abstract Slides Video

Access the full session

Session thumbnail

Rapid fire abstracts session 1 - Secondary Prevention and Rehabilitation

The Event

Event poster

ESC Preventive Cardiology 2022

7 April 2022 18:09 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources